Impact of a mindfulness based intervention on chemotherapy-induced cognitive dysfunction

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON28465

Enrollment

Registered

2017-02-14

Start date

2017-02-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

This study aims to assess the impact of a mindfulness based intervention on the cognitive complaints and cognitive impairment after cancer treatment.

Interventions

A mindfulness-based intervention.

Eligibility

Inclusion criteria

Inclusion criteria: - Early stage breast-cancer (no metastases) - Chemotherapy as (neo-)adjuvant therapy - > 2 months and < 2 years after chemotherapy - younger than 60 years at time of diagnosis - cognitive complaints

Exclusion criteria

Exclusion criteria: - mental retardation - psychological disorder (e.g. depression, anxiety, psychosis) - neurological disorder - experience with mindfulness meditation

Design outcomes

Primary

Measure	Time frame
- MRI imaging - neuropsychological test battery covering attention and concentration, memory, executive functioning, cognitive/psychomotor processing speed	—

Secondary

Measure	Time frame
- fatigue - symptoms of depression, anxiety and stress - quality of life	—

Contacts

Public ContactKathleen Gucht, van der

Ku Leuven Faculty of Psychology & Educational Sciences Tiensestraat 102 (box 3720)

katleen.vandergucht@ppw.kuleuven.be-

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)